EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Increased IL- 36γ in visceral adipose tissue as a key mediator of obesity-driven inflammation in colon cancer

Gema Frühbeck, Sofía Criado, Javier Gómez-Ambrosi, Beatriz Ramírez, Sara Becerril, Amaia Rodríguez, Gabriela Neira, Laura Salmón-Gómez, Víctor Valentí, Rafael Moncada, Jorge Baixauli, Camilo Silva und 1 weitere

Journal of Molecular Medicine · 2025-06 · 103 (6) · 699-711

DOI: 10.1007/s00109-025-02546-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Molecular Medicine, online erschienen am 23.04.2025. Verfasst von Gema Frühbeck und 12 weiteren Autor:innen. Beteiligte Einrichtung: Metabolic Research Laboratory, Cancer Center Clínica Universidad de Navarra (CCUN), Avda. Pío XII, 36, 31008, Pamplona, Spain. gfruhbeck@unav.es. Hauptthemen laut MEDLINE: Obesity, Intra-Abdominal Fat, Colonic Neoplasms, Inflammation. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III, Dpt of Health. Gobierno de Navarra, CIBEROBN.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dysfunctional adipose tissue (AT) in the context of obesity promotes a chronic inflammatory state, associated with worse cancer progression and prognosis. Interleukin (IL)-36γ is a proinflammatory factor increased in obesity. The aim was to analyse the role of IL-36γ in colon cancer (CC) development in patients with obesity. Samples obtained from 74 volunteers (27 with normal weight (NW) and 47 with obesity (OB)) were used in a case–control study. Participants were also subclassified according to the presence of CC (45 without and 29 with CC). HT-29 cells were treated with pro-inflammatory factors, adipocyte conditioned media (ACM) and IL-36γ to evaluate the expression levels of inflammation- and extracellular matrix (ECM) remodelling-related molecules. Increased gene expression levels of IL36G and IL36R in visceral AT from patients with OB and CC were found. Moreover, mRNA levels of IL36G were significantly associated with the gene expression levels of its receptor and relevant genes involved in AT inflammation ( ASC , IL1B and NLRP6 ). Consistently, IL36G expression was upregulated by hypoxia, inflammation-related factors (LPS, TNF-α and leptin) and by the adipocyte secretome from patients with obesity in HT-29 cancer cells. Furthermore, we revealed that IL-36γ increased the gene expression levels of inflammation-related genes ( IL36G , IL1 A , IL1B , IL6 , IL8 and NGAL ) as well as ECM markers ( MMP9 , SPP1 and TNC ) in HT-29 cells. Increased gene expression levels of IL36G in VAT from patients with OB and CC may promote a pro-inflammatory microenvironment favourable for tumour progression and migration. Key messages Obesity and colon cancer increase gene expression levels of IL36G and IL36R in visceral adipose tissue. Hypoxia, inflammation-related factors and the adipocyte secretome from patients with obesity upregulate mRNA levels of IL36G in HT-29 cancer cells. IL-36γ increase the gene expression levels of inflammation-related genes ( IL36G , IL1A , IL1B , IL6 , IL8 and NGAL ) as well as ECM markers ( MMP9 , SPP1 and TNC ) in HT-29 cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ObesityIntra-Abdominal FatColonic NeoplasmsInflammationInterleukin-1HumansMaleFemaleMiddle AgedHT29 CellsCase-Control StudiesAged

Stichwörter der Autor:innen

Colon cancerInflammationInterleukin- 36ObesityVisceral adipose tissue

Substanzen

Interleukin-1IL36G protein, human

Autor:innen und Institutionen

  • Metabolic Research Laboratory, Cancer Center Clínica Universidad de Navarra (CCUN), Avda. Pío XII, 36, 31008, Pamplona, Spain. gfruhbeck@unav.es.
  • CIBER Fisiopatología de La Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, Pamplona, Spain. gfruhbeck@unav.es.
  • Obesity and Adipobiology Group, Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain. gfruhbeck@unav.es.
  • Department of Endocrinology & Nutrition, Cancer Center Clínica Universidad de Navarra (CCUN), Avda. Pío XII, 36, 31008, Pamplona, Spain. gfruhbeck@unav.es.
  • Metabolic Research Laboratory, Cancer Center Clínica Universidad de Navarra (CCUN), Avda. Pío XII, 36, 31008, Pamplona, Spain.
  • CIBER Fisiopatología de La Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, Pamplona, Spain.

Förderung

  • Instituto de Salud Carlos III
  • Dpt of Health. Gobierno de Navarra
  • CIBEROBN
  • Universidad de Navarra

Zitieren

APA

Frühbeck, G., Criado, S., Gómez-Ambrosi, J., Ramírez, B., Becerril, S., Rodríguez, A., Neira, G., Salmón-Gómez, L., Valentí, V., Moncada, R., Baixauli, J., Silva, C., & Catalán, V. (2025). Increased IL- 36γ in visceral adipose tissue as a key mediator of obesity-driven inflammation in colon cancer. Journal of Molecular Medicine, 103(6), 699-711. https://doi.org/10.1007/s00109-025-02546-9

Vancouver

Frühbeck G, Criado S, Gómez-Ambrosi J, Ramírez B, Becerril S, Rodríguez A, et al. Increased IL- 36γ in visceral adipose tissue as a key mediator of obesity-driven inflammation in colon cancer. Journal of Molecular Medicine. 2025;103(6):699-711. doi:10.1007/s00109-025-02546-9

BibTeX
@article{Frhbeck2025,
  author = {Frühbeck, Gema and Criado, Sofía and Gómez-Ambrosi, Javier and Ramírez, Beatriz and Becerril, Sara and Rodríguez, Amaia and Neira, Gabriela and Salmón-Gómez, Laura and Valentí, Víctor and Moncada, Rafael and Baixauli, Jorge and Silva, Camilo and Catalán, Victoria},
  title = {Increased IL- 36γ in visceral adipose tissue as a key mediator of obesity-driven inflammation in colon cancer},
  journal = {Journal of Molecular Medicine},
  year = {2025},
  volume = {103},
  number = {6},
  pages = {699--711},
  doi = {10.1007/s00109-025-02546-9}
}
Kostenlos starten →